Navigation Links
Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
Date:9/16/2008

Named Patient Programmes Yield ROI, Additional Benefits for Pharmaceutical

Organizations

NEW YORK and LONDON, Sept. 16 /PRNewswire/ -- Eularis today announced the release of a first-ever study on the ROI of named patient programmes (NPP), also known as compassionate use programs. The paper, "Implementing a pre-launch named patient programme -- evidence of increased market share," provides pharmaceutical companies with insight and mathematical justification into the cash market share and revenue impact of pre-launch NPPs on brands, while outlining the benefits and challenges that they create.

NPPs provide pharmaceutical and biotechnology companies with a way to ethically provide pre-launch medicines available in countries outside of the approved markets. Through these programmes, patients with a genuine unmet medical need are able to access the potentially live-saving medicines before those medicines are licensed and commercially available in their home country. By implementing an NPP, companies increase patient access to new treatment options and in turn create additional revenue opportunities.

While many companies have employed NPPs in an effort to manage patient access, maximize market share and optimize profits, until now, no studies have been conducted reporting on the efficacy of these programmes. In a market environment where an effective launch can result in success or failure of a pharmaceutical, evidence-based strategy is essential to launching and maintaining a successful product. The study reports on the positive ROI and increased launch market share that can be achieved by using NPP programmes pre-launch. The study used a control group of brands that had not used NPP, and matched these with brands that had, across multiple countries and therapeutic categories. The paper also reports on additional non-financial benefits such as product visibility and physician cultivation and relationship developme
'/>"/>

SOURCE Eularis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ALEM and NEEDHAM, Massachusetts, December 3 /PRNew...s Exchange: ORIDN) today announced that the Bavari...graphs for its RTW (Rettungswagen) medical vehicle... to assess the ventilation status of a patient as ...ry status such as displaced endotracheal tubes, ep...
(Date:12/2/2009)...YORK, Dec. 2 Reportlinker.com ann...ble in its catalogue: ,, Hospital Information ...pportunities ,, http://www.reportlinker.com/p...date-of-Market-Trends--Opportunities.html ,, I...on the benefits of using Information Technology in...
(Date:12/2/2009)...YORK, Dec. 2 Reportlinker.com anno...le in its catalogue: ,, Electrodes for Medical...p://www.reportlinker.com/p0164320/Electrodes-for-M... ,, Electrodes in electronic devices detect ele...s that are created by chemical reactions. Medical ...
Breaking Medicine Technology:Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 2Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 3Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 4Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 5Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 6Reportlinker Adds Electrodes for Medical Devices - A Global Market Perspective 7ATS Medical to Participate at Upcoming Investor Conferences 52888 1ATS Medical to Participate at Upcoming Investor Conferences 52888 2Ecigarettesnational com Says Claim by FDA and Other Health Organizations Intentionally Misleading 52883 1Ecigarettesnational com Says Claim by FDA and Other Health Organizations Intentionally Misleading 52883 2Ecigarettesnational com Says Claim by FDA and Other Health Organizations Intentionally Misleading 52883 3DaVita Hosts National Quality Week 2009 52878 1DaVita Hosts National Quality Week 2009 52878 2
...ollowing is being,issued by R-CALF United Stockgro...ws conference about the lawsuit it and,10 other pl...culture (USDA),to prevent the agency from allowing...beef products from Canadian cattle over 30 months ...tiffs maintain that Canada,s problems,with bovine ...
...C., Oct. 31 AlphaVax, Inc.,announced today that i...lunteers of an influenza vaccine based on its prop...esigned to further assess the properties of this,u...its application to,influenza vaccines. The study ... trial in,healthy adults, 18-40 years old, which e...
Other Medicine Technology:R-CALF United Stockgrowers of America: 'Fighting for the U.S. Cattle Producer' 2AlphaVax Announces Results From Phase 1 Influenza Vaccine Clinical Trial 2
(Date:12/3/2009)...esidue in those who rise and smoke, , ,...a cigarette first thing in the morning? If so, tak...nd smoke inhale more nicotine than other smokers. ...of the researchers said he thinks it could be a si...r drags on their cigarettes. And that, he said, co...
(Date:12/3/2009)... Dec. 3 Hair Fairies, the head lic...hat Santa Claus will be helping out every Saturday... will listen to children,s wish lists, and hand ou...airies technicians take care of the head lice ,...g Santa. During Hanukkah, Hair Fairies Salons will...
(Date:12/3/2009)...Dec. 3 The Redwood Ga...ws" for patients who are struggling financially an...Partnership for Prescription Assistance ( PPA ) h...ms providing prescription medicines for free or ne... Assistance has access to information on more than...
(Date:12/3/2009)...rchers are warning that some of the most important...mental health, yet this issue is unlikely to be gi...ence in Copenhagen next week. , Dr Lisa Page and... (IoP) at King,s College London reviewed a range o... mental health impacts of climate change. , In ...
(Date:12/3/2009)... Arthritis Foundation bestowed its highest nationw...its national meeting in Atlanta. , ...s Foundation bestowed its highest nationwide honor...nal meeting on Nov. 20 in Atlanta. The honorees a...istinguished Service ,The Arthritis Foundation hon...
Breaking Medicine News(10 mins):Health News:Early Morning Smokers May Be More Dependent on Nicotine 2Health News:Santa Claus Helps Hair Fairies Keep the Holidays Free from Head Lice 2Health News:Santa Claus Helps Hair Fairies Keep the Holidays Free from Head Lice 3Health News:Major impacts of climate change expected on mental health 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4
...AM, NC A novel drug designed to lessen muscle dam...tests at the Duke Clinical Research Institute. Res...ished in the February 19 issue of the journal Circ...tein kinase C that triggers cell and tissue death ...
...RGH, Feb. 7 MED3OOO Inc., a national healthcare,m...agreement with St.,Mary,s Medical Center of Huntin...ement (RCM), ASP PM technology, consulting and cod...ral specialties. MED3OOO,s subsidiary,MED3OOO Heal...
...L, Feb. 7 /PRNewswire-FirstCall/ - DRAXIS Health I...l results for the fourth quarter and,the year ende...r of 2007,compared to the fourth quarter of 2006 w...stronger Canadian dollar in the,fourth quarter of ...
...IS, Feb. 7 Stereotaxis, Inc. (Nasdaq:,STXS) today...-year,unsecured loan commitments from two current ...the commitment for an additional 90 days, at its o...,Stereotaxis agreed to grant to the investors comm...
...Event Brings Leading Clean Indoor Air and Health A...Improving Poor Indoor Air Quality, SOUTHBOROUGH, ...gers of outdoor air pollution. But did you know th...n outdoor air,pollution levels? Five out of 10 Ame...
...mpanies to offer as employee benefit Increasing ...ouble industry,s size by 20...ndustry is,going to the dogs ... and cats., Offic...accelerate in 2008. As a nationwide provider of he...
Other Medicine News:Health News:Novel compound may lessen heart attack damage 2Health News:St. Mary's Medical Center Renews RCM & Technology With MED3000 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 3Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 4Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 5Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 6Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 7Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 8Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 9Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 10Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 11Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 12Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 13Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 14Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 15Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 16Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 17Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 18Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 19Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 20Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 21Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 22Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 23Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 24Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 25Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 26Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 27Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 28Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 29Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 30Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 31Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 32Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 33Health News:Stereotaxis Receives $20 Million in Additional Loan Commitments 2
Replacement Handle
Replacement Needle Tip
Needle and Gouge Spud Set
Storz Corneal Burr
Medicine Products: